
Two groups join up to help the Massachusetts State Office of Pharmacy Services.
Younger people, females, black or Hispanic less likely to have medication.
Report looks at possible impediments to growth in the specialty market, including patient access.
High court ruling should make biosimilars available faster.
Patients are less like to buy a requested brand name prescription than a generic one.
So just how much naloxone is getting out? How many pharmacies EPCS enabled?
The recall is a major setback in the ongoing sodium bicarbonate shortage.
Is your immunization knowledge up-to-date?
The IACP is excited about new legislation that could help compounding pharmacists.
The AMA is pushing for greater drug pricing transparency.
A new law would limit emergency immunization for children entering foster care system in Texas.
The FDA found uncontrolled manufacturing practices.
The U.S. Army wants to grant an exclusive license for a Zika vaccine, but there are worries that exclusivity would lead to a high price.
After repeated infractions, a company is forced to shutter its doors.
A new study shows how the Medicare donut hole could be costing patients.
More information could help save lives.
Because of the NECC Case, the nation has a much more consistent approach toward regulating and overseeing compounding pharmacies.
AACP offers a rebuttal to a Drug Topics opinion article.
New technology is helping patients, nurses, and pharmacists alike.
Vaccinations in adulthood play an important role in public health and in reducing the morbidity and mortality associated with infections.
Pete Kreckel has a love hate relationship with technology.
As the opioid crisis worsens, debates rage about the best methods to combat it.
How women are becoming more involved than ever in pharmacy.
How one opioid abuse deterrent could make it easy to identify misuse.
The U.S. market remains the largest single-country market in the world.
Telepharmacy is more than just phoning it in. It could expand the number of jobs for pharmacists and their access to patients who are otherwise out of reach.
How value assessment tools enhance decision-making in oncology.